SOX2 and cancer: The CCK8 assay indicated that at the 48 h time, the proliferation of HepG2 cells was inhibited by siR-Sox2 loaded CNVs ranging from 2 × 108 to 1.28 × 1010, demonstrating the anti-cancer effect of siR-Sox2 (Supplementary Fig. 5b).